REDMILE GROUP, LLC


Description of Advisory Firm. Redmile Group, LLC (the “Firm” or “Redmile”), a Delaware limited liability company, was formed in March 2007 and became operational shortly thereafter. Jeremy Green is the managing member and principal owner of the Firm. The Firm generally provides investment management and advisory services to private investment funds (“Funds”) that are exempt from registration under the Investment Company Act of 1940, as amended, and separately managed accounts. The Firm focuses primarily on making investments in U.S. and non- U.S. healthcare companies. The Firm provides investment management and advisory services to two types of Funds: pooled investment vehicles (the “Pooled Investment Vehicles”) and Delaware limited partnerships that are structured similarly to venture capital investment vehicles (the “VC Partnerships”). The Pooled Investment Vehicles consist of U.S. and non-U.S. private investment funds. They include a Delaware limited partnership and a Cayman Islands exempted company that invest directly, as well as a Delaware limited partnership and Cayman Islands exempted companies that invest substantially all of their assets in a Cayman Islands exempted limited partnership or a Cayman Islands exempted company via a master-feeder or mini-master feeder structure. One of the Cayman Islands exempted companies that invests directly (the “ERISA Fund”) is designed to accept subscriptions from pension and profit-sharing plans maintained by U.S. corporations and unions, individual retirement accounts and Keogh plans, entities that invest the assets of such accounts or plans and other entities investing plan assets (“Benefit Plan Investors”). Redmile Group (GP), LLC and Redmile Group (GP) II, LLC (each, a “General Partner” and together, the “General Partners”), both Delaware limited liability companies and affiliates of Redmile, serve as the general partner or special shareholder of certain of these Pooled Investment Vehicles. The VC Partnerships are organized as Delaware limited partnerships or Cayman Islands limited partnerships. Redmile Private Investments I (GP), LLC (the “VC General Partner I”), Redmile Private Investments II (GP), LLC (the “VC General Partner II”), Redmile Biopharma Investments I (GP), LLC (previously doing business as Redmile Biotechnologies Investments I (GP), LLC) (the “VC Biopharma I General Partner”) and Redmile Biopharma Investments II (GP), LLC (the “VC Biopharma II General Partner”) are Delaware limited liability companies and RAF GP, LLC is a Cayman Islands limited liability company (the “RAF General Partner”, and collectively with the VC General Partner I, the VC General Partner II, the VC Biopharma I General Partner and the VC Biopharma II General Partner, the “VC General Partners”) that each serve as general partner to a VC Partnership. Description of Advisory Services. The Firm manages the portfolios of the Pooled Investment Vehicles and other clients on a discretionary or non-discretionary basis according to the investment objectives and restrictions of each Pooled Investment Vehicle or client. The investment objective and strategy for each Pooled Investment Vehicle is described in more detail in its respective offering materials. Please see Item 8 for a more detailed description of the strategies pursued by the Pooled Investment Vehicles. Redmile provides portfolio management and advisory services for the VC Partnerships. Redmile manages the VC Partnerships in accordance with the investment objective and investment strategy described in their respective offering documents, which may include a confidential private placement memorandum, limited partnership agreement, subscription agreement and subscription questionnaire. Redmile also serves as the investment manager to separately managed accounts. In this capacity, Redmile provides portfolio management and advisory and other services to specific accounts. Redmile works with each of its separately managed account clients to develop investment guidelines based upon the client’s specific investment objectives. Separately managed accounts are typically governed by a written agreement between the separately managed account client that may provide more favorable terms than those of the Pooled Investment Vehicles, including with respect to management fees, performance fees and liquidity, among other terms. Separately managed account clients may amend their investment guidelines as their needs change or impose restrictions on investing in certain securities or types of securities. Client Tailored Services and Client Imposed Restrictions. Redmile does not tailor its portfolio management services to the individual needs of investors in the Funds. Wrap Fee Programs. Redmile does not participate in wrap fee programs. Assets Under Management. As of January 31, 2019, Redmile had client net assets under management of approximately $3.8 billion. please register to get more info

Open Brochure from SEC website
Assets
Pooled Investment Vehicles $7,726,270,888
Discretionary $7,726,270,888
Non-Discretionary $
Registered Web Sites

Related news

Startup Scene: Here's how Ohio State plans to support more startups

Ohio State University’s new research and innovation chief is bullish on increasing the number of startups supported by the university and formed under its wing. Grace Jinliu Wang joined the university Dec.

Vesper Healthcare Acquisition Corp

REDMILE GROUP, OTHERS.VESPER HEALTHCARE ACQUISITION CORP - VESPER HEALTHCARE, LINDEN AND DWHP WILL EACH RETAIN AN EQUITY STAKE IN COMBINED COMPANY. Vesper Healthcare Acquisition Is Set To Combine ...

Is KYMR A Good Stock To Buy Now According To Hedge Funds?

Trailing Redmile Group was Biotechnology Value Fund / BVF Inc, which amassed a stake valued at $85 million. Baker Bros. Advisors, Rock Springs Capital Management, and Logos Capital were also very ...

Is IMTX A Good Stock To Buy Now According To Hedge Funds?

Redmile Group, Alyeska Investment Group, and 683 Capital Partners were also very fond of the stock, becoming one of the largest hedge fund holders of the company. In terms of the portfolio weights assigned to each position Beryl Capital Management ...

Is EPZM A Good Stock To Buy Now According To Hedge Funds?

Redmile Group has a $99.2 million position in the stock, comprising 1.8% of its 13F portfolio. Sitting at the No. 2 spot is Palo Alto Investors, managed by William Leland Edwards, which holds a $76.4 million position; the fund has 4.2% of its 13F portfolio ...

Tapping AI and cash from VC's new fund, startup emerges with focus on Parkinson's, MS

Neuron23 Inc., which quietly raised an initial $33.5 million two years ago from Westlake Village BioPartners and Kleiner Perkins, said Wednesday that it took on another $80 million in a round led by Redmile Group ... a $430 million fund that will support ...

Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group

Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, today announced its launch backed by a combined $113.

Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group

Westlake's investment in the Series B round for Neuron23 came from its Opportunity 1 fund, one of the new funds ... biopartners-kleiner-perkins-and-redmile-group-301192555.html SOURCE Neuron23 ...

Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group

Westlake's investment in the Series B round for Neuron23 came from its Opportunity 1 fund, one of the new funds ... biopartners-kleiner-perkins-and-redmile-group-301192555.html SOURCE Neuron23 ...

Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group

The funding was comprised of $33.5 million Series A financing from Westlake Village BioPartners and Kleiner Perkins, and $80 million Series B financing led by Redmile Group. Additional Series B ...
Loading...
No recent news were found.